HANGZHOU MEDCONN DIAGNOSTICS TECHNOLOGY CO. LTD
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument for chromatography analysis, LYSIS SOLUTION
Explore comprehensive manufacturer profile for HANGZHOU MEDCONN DIAGNOSTICS TECHNOLOGY CO. LTD based in China through Pure Global AI's free Brazil medical device database. This manufacturer has 3 products registered with ANVISA across 3 unique technical categories. Their regulatory history spans from Sep 22, 2025 to Feb 18, 2026.
This page provides detailed insights including 3 recent product registrations including LYSIS SOLUTION, 3 most popular products with LYSIS SOLUTION having 1 registrations, 1 registration holders including KATAL BIOTECNOLOGICA INDUSTRIA E COMERCIO LTDA, and 5 key competitors with SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD sharing 3 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.